The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD

Clinical trial NCT00163059 · COMPLETED

Trial details

NCT number: NCT00163059
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2004-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.